One of the key takeaways from the meeting, and from phase I of CHL UK, was that we tested and learned together for a whole year, but it’s now time to put our energy into what works.
Novartis has renewed its pledge with the World Health Organization (WHO) to work to end leprosy by extending its donation of multidrug therapy (MDT) medicines to treat leprosy through the year 2020. This five-year agreement includes treatments worth more than USD 40 million and up to USD 2.5 million to support the WHO in handling the donation and logistics. Overall it is expected that the program will reach an estimated 1.3 million patients during the next five years. This is part of the company’s commitment in 2012 to the London Declaration on Neglected Tropical Diseases.
AEG embraces its responsibility to enrich the lives of people in the communities around the world where we do business, and to use business to create...
Focus on preventing and treating malnutrition across life stages. Highlights include early detection, community-based treatment (e.g., MUAC screening...
Corporate governance, risk management, operational integrity, and regulatory compliance are demanding challenges that companies face in today’s ever...
Since the launch of the Subaru Share the Love Event in 2008, Subaru of America and our retailers have donated more than $256 million to charity, with...
